Picture a web meeting. The people on the monitors will be a panel of people with ALS and caregivers. The people at the table will be FDA officials. Each FDA person has six minutes to give his or her perspectives on ALS drug development and approval to the panel of patients and caregivers.
Hmmmmmm.
No comments:
Post a Comment